your catalystto a lucrative business sevoflurane n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Sevoflurane, Isoflurane and Desflurane Industry Analysis PowerPoint Presentation
Download Presentation
Sevoflurane, Isoflurane and Desflurane Industry Analysis

Loading in 2 Seconds...

play fullscreen
1 / 4

Sevoflurane, Isoflurane and Desflurane Industry Analysis - PowerPoint PPT Presentation


  • 6 Views
  • Uploaded on

The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong and cost less, with minimum damage to the ozone layer.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Sevoflurane, Isoflurane and Desflurane Industry Analysis' - Marsh


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
your catalystto a lucrative business sevoflurane

Your CatalystTo a Lucrative Business

Sevoflurane, Isoflurane and Desflurane Market Share, Size,

Analysis, Growth, Trends and Forecasts to 2022 | Hexa Research

“The Sevoflurane, Isoflurane and Desflurane Market is

expected to reach USD 1.5 billion by 2022 in comparison to

USD 1.2 billion in 2014.”

The Sevoflurane, Isoflurane and Desflurane Market is expected to reach USD 1.5 billion by 2022 in comparison

to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by

anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very strong

and cost less, with minimum damage to the ozone layer.

Market Drivers

One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market includes

cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer, orthopedic, spinal and

gastro-intestinal cases have also furthered the market. Cataract surgery is a major contributor to the global

market and will need a higher production of these chemicals.

Growing accidents and emergency cases also add income to the inhalation anesthesia market. Universal

insurance coverage as well as constant improvements in medical infrastructure also ensure the development of

the sevoflurane, isoflurane and desflurane market. These agents are administered to patients prior surgery,

making the induction of general anesthesia much simpler.

A major factor hindering the market is the quantity of CO2 released in the environment, leading to global

warming. Actually, only about 5 percent of the gases are consumed by patients. The rest are released into the

atmosphere and make it unhealthy. The most practical solution for this problem is the anesthetic recycling of

products used during the administration of general anesthesia.

Browse Details of Report@

https://www.hexaresearch.com/research-report/sevoflurane-isoflurane-desflurane-industry

Follow Us:

your catalystto a lucrative business

Your CatalystTo a Lucrative Business

Products Overview

Sevoflurane

Sevoflurane is one of the most commonly used volatile anesthetic agents. It is administered to babies and

children. Sevoflurane is ideal for patients with asthma or sensitive air passages. But its side-effects include

delirium and agitation. It can be given quickly without the use of intravenous instruments.

Sevoflurane would capture over 70% of the worldwide sevoflurane, isoflurane and desflurane market by 2022.

The agent is expected to exceed USD 1 billion by the same year. It’s widely utilized for being low-priced and

possessing therapeutic benefits.

Isoflurane

Isoflurane is a halogen ether utilized frequently by veterinarians. It is administered intravenously, relaxes the

muscles and reduces pain. Isoflurane has also been used for inducing sleepiness for long durations during

surgery. It is expected to register a CAGR of about 10% by 2022.

Desflurane

Desflurane is a halogen ether used in general anesthesia. Its effectiveness is one-fifth of isoflurane. Desflurane

cannot be administered orally and requires an electrically heated dispenser to distribute the vapor. It is mostly

administered to bariatric patients and in cases of surgeries lasting for short durations.

Regional Overview

The United States has a large geriatric population. This has led the region of North America to occupy the

biggest share in the worldwide inhalation anesthesia market in 2014. Surgical ambulatory and inpatient

procedures are the driving factors of North America.

Asia Pacific will experience the fastest growth by 2022. This is owing to the rise of chronic diseases and need for

better health infrastructure in the region. Medical tourism combined with insurance coverage will play a huge

role in sustaining the growth of the sevoflurane, isoflurane and desflurane market.

Key Players

The market is currently dominated by AbbVie and Baxter International. However, it can expect strong

competition from manufacturers like Lunan Pharmaceutical Group and Piramal Enterprises.

Piramal Enterprises currently has isoflurane and sevoflurane production underway. It will manufacture generic

desflurane by 2016. AbbVie has sevoflurane and isoflurane under production. Baxter International is the only

one that manufactures all the three products.

Anesthesia has some unhealthy effects. The recycling companies of Deltasorb Technologies and Anesthetic Gas

Reclamation reprocess anesthesia containers and gases from hospital vents. Rising investments by the

aforementioned players would also accelerate the sales of the sevoflurane, isoflurane and desflurane market.

Browse Related Category Market Reports@

https://www.hexaresearch.com/research-category/pharmaceuticals-industry

Follow Us:

your catalystto a lucrative business 1

Your CatalystTo a Lucrative Business

Table of Content of Sevoflurane, Isoflurane and Desflurane Market

Executive Summary & Digital Transformation industry critical success factors

Industry Outlook

Industry Dynamics

Digital Transformation Market drivers

Digital Transformation Market restraints

Digital Transformation Key Market Opportunities

Digital Transformation Porters Analysis

Digital Transformation - PESTEL Analysis

Digital Transformation - Company Market Share Analysis

Digital Transformation Application Outlook

Digital Transformation Regional Outlook

Digital Transformation Company profiles

Research Methodology

Research scope & assumptions

List of data sources

Follow Us:

your catalystto a lucrative business 2

Your CatalystTo a Lucrative Business

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research

and consulting services to a host of key industries across the globe. We offer comprehensive business

intelligence in the form of industry reports which help our clients obtain clarity about their business

environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow Us: